Literature DB >> 22578249

Molecular mechanism of Jmjd3-mediated interleukin-6 gene regulation in endothelial cells underlying spinal cord injury.

Kwanghyun Lee1, Wonho Na, Jee Youn Lee, Jungtae Na, Heejung Cho, Hongjin Wu, Tae Young Yune, Won-Sun Kim, Bong-Gun Ju.   

Abstract

The inflammatory response contributes substantially to secondary injury cascades after spinal cord injury, with both neurotoxic and protective effects. However, epigenetic regulations of inflammatory genes following spinal cord injury have yet to be characterized thoroughly. In this study, we found that histone H3K27me3 demethylase Jmjd3 expression is acutely up-regulated in blood vessels of the injured spinal cord. We also observed up-regulation of Jmjd3 gene expression in bEnd.3 endothelial cells that were subjected to oxygen-glucose deprivation/reperfusion injury. When Jmjd3 was depleted by siRNA, oxygen-glucose deprivation/reperfusion injury-induced up-regulation of IL-6 was significantly inhibited. In addition, Jmjd3 associated with NF-κB (p65/p50) and CCAAT-enhancer-binding protein β at the IL-6 gene promoter. The recruitment of Jmjd3 coincided with decreased levels of tri-methylated H3K27 as well as increased levels of mono-methylated H3K27 at the IL-6 gene promoter. Furthermore, Jmjd3 depletion did not result in significant changes of methylation level of H3K27 at the IL-6 gene promoter. Collectively, our findings imply that Jmjd3-mediated H3K27me3 demethylation is crucial for IL-6 gene activation in endothelial cells, and this molecular event may regulate acute inflammatory response and integrity of the blood-spinal cord barrier following spinal cord injury.
© 2012 The Authors. Journal of Neurochemistry © 2012 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22578249     DOI: 10.1111/j.1471-4159.2012.07786.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  24 in total

1.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

2.  Dexamethasone suppresses JMJD3 gene activation via a putative negative glucocorticoid response element and maintains integrity of tight junctions in brain microvascular endothelial cells.

Authors:  Wonho Na; Jee Y Shin; Jee Y Lee; Sangyun Jeong; Won-Sun Kim; Tae Y Yune; Bong-Gun Ju
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-24       Impact factor: 6.200

Review 3.  Histone demethylase Jumonji D3 (JMJD3/KDM6B) at the nexus of epigenetic regulation of inflammation and the aging process.

Authors:  Antero Salminen; Kai Kaarniranta; Mikko Hiltunen; Anu Kauppinen
Journal:  J Mol Med (Berl)       Date:  2014-06-14       Impact factor: 4.599

4.  JMJD3 regulates CD4 T cell trafficking by targeting actin cytoskeleton regulatory gene Pdlim4.

Authors:  Chuntang Fu; Qingtian Li; Jia Zou; Changsheng Xing; Mei Luo; Bingnan Yin; Junjun Chu; Jiaming Yu; Xin Liu; Helen Y Wang; Rong-Fu Wang
Journal:  J Clin Invest       Date:  2019-08-08       Impact factor: 14.808

5.  17β-Estradiol Ameliorates Tight Junction Disruption via Repression of MMP Transcription.

Authors:  Wonho Na; Jee Youn Lee; Won-Sun Kim; Tae Young Yune; Bong-Gun Ju
Journal:  Mol Endocrinol       Date:  2015-07-13

6.  Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B.

Authors:  Dania Al Labban; Seung-Hee Jo; Paola Ostano; Chiara Saglietti; Massimo Bongiovanni; Renato Panizzon; G Paolo Dotto
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

7.  Runt-related Transcription Factor 1 (RUNX1) Binds to p50 in Macrophages and Enhances TLR4-triggered Inflammation and Septic Shock.

Authors:  Mao-Cai Luo; Si-Yuan Zhou; Dan-Ying Feng; Jun Xiao; Wei-Yun Li; Chun-Di Xu; Hong-Yan Wang; Tong Zhou
Journal:  J Biol Chem       Date:  2016-08-29       Impact factor: 5.157

Review 8.  Developing epigenetic diagnostics and therapeutics for brain disorders.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Trends Mol Med       Date:  2013-10-18       Impact factor: 11.951

9.  Jmjd3-mediated epigenetic regulation of inflammatory cytokine gene expression in serum amyloid A-stimulated macrophages.

Authors:  Qian Yan; Lei Sun; Ziyan Zhu; Lili Wang; Shuqin Li; Richard D Ye
Journal:  Cell Signal       Date:  2014-04-01       Impact factor: 4.315

10.  Further insight into molecular mechanism underlying thoracic spinal cord injury using bioinformatics methods.

Authors:  Weiguo Wang; Rongjun Liu; Zhanwang Xu; Xiufeng Niu; Zhaohu Mao; Qingxi Meng; Xuecheng Cao
Journal:  Mol Med Rep       Date:  2015-10-14       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.